Back to News
Market Impact: 0.35

Should You Buy Palantir Stock Before Year-End?

PLTRPYPLNFLXNVDANDAQ
Artificial IntelligenceTechnology & InnovationProduct LaunchesCompany FundamentalsCorporate EarningsAnalyst EstimatesAnalyst InsightsInvestor Sentiment & Positioning
Should You Buy Palantir Stock Before Year-End?

Palantir’s shift from a government-focused data-analytics provider to a commercial AI workflow platform with its Artificial Intelligence Platform (AIP) has driven materially faster top-line growth—revenue growth accelerated from 13% in Q2 2023 to 63% in the most recent quarter, U.S. commercial revenue rose 121% YoY in Q3, customer count is up 45% YoY and 12-month net revenue retention is 134%—as clients deploy AIP to reduce AI hallucinations and operationalize models. Despite the strong fundamentals and the stock’s dramatic run (more than quadrupling in 2024 and up ~147% year‑to‑date), the shares now trade at frothy multiples (roughly 70x 2026 P/S and ~183x forward P/E), and the author cautions against buying at current levels while acknowledging Palantir’s long‑term potential as a major AI infrastructure player, suggesting investors wait for a meaningful pullback.

Analysis

Palantir has repositioned from a government-focused analytics firm to a commercial AI workflow platform with the 2023 launch of its Artificial Intelligence Platform (AIP); AIP organizes disparate customer data into ontologies to reduce AI hallucinations and serve mission‑critical applications. AIP adoption coincides with accelerating top-line trends: revenue growth rose from 13% in Q2 2023 to 63% in the most recent quarter, U.S. commercial revenue increased 121% year‑over‑year in Q3, customer count is up 45% YoY, and 12‑month net revenue retention is 134%. The stock has delivered outsized returns—more than quadrupling in 2024 and up roughly 147% year‑to‑date—but valuation is extremely rich, trading near 70x 2026 price‑to‑sales and about 183x forward P/E. The article underscores that the U.S. government remains Palantir's largest client even as commercial demand leads growth, and the author cautions against initiating new positions at current multiples despite the company’s long‑term potential. Elevated multiples materially raise downside risk if execution or macro conditions slip, and the author recommends waiting for a meaningful pullback before buying; historical precedent for large-cap leaders shows large interim drawdowns are common. Investors should therefore track execution metrics (commercial revenue growth, customer additions, and net revenue retention) as primary triggers and favor phased or hedged exposure rather than full, unprotected commitments at today’s valuations.